Literature DB >> 23049459

Management of immune thrombocytopenic purpura: an update.

Rajasekharan Warrier1, Aman Chauhan.   

Abstract

Rapid strides have been made in the field of hematology, and advances in immune thrombocytopenic purpura (ITP) management are no exception. From idiopathic to immune, the changed nomenclature is itself a testimonial to the growing awareness and improvements in the management of ITP. We discuss the pathophysiology, clinical presentation, and current management of this common pediatric disorder and summarize current guidelines for ITP treatment.

Entities:  

Keywords:  Immune thrombocytopenia; purpura

Year:  2012        PMID: 23049459      PMCID: PMC3448244     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  38 in total

Review 1.  Immune thrombocytopenic purpura.

Authors:  Douglas B Cines; Victor S Blanchette
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

Review 2.  Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

Authors:  Donald M Arnold; Francesco Dentali; Mark A Crowther; Ralph M Meyer; Richard J Cook; Christopher Sigouin; Graeme A Fraser; Wendy Lim; John G Kelton
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 3.  Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

Authors:  J N George; S H Woolf; G E Raskob; J S Wasser; L M Aledort; P J Ballem; V S Blanchette; J B Bussel; D B Cines; J G Kelton; A E Lichtin; R McMillan; J A Okerbloom; D H Regan; I Warrier
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

4.  Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.

Authors:  A Scaradavou; B Woo; B M Woloski; S Cunningham-Rundles; L J Ettinger; L M Aledort; J B Bussel
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

5.  Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

Authors:  A Samuelsson; T L Towers; J V Ravetch
Journal:  Science       Date:  2001-01-19       Impact factor: 47.728

6.  Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura.

Authors:  J van Hoff; A K Ritchey
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

Review 7.  Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.

Authors:  A R Gaines
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

8.  High-dose steroids in childhood acute idiopathic thrombocytopenia purpura.

Authors:  C R Suarez; D Rademaker; A Hasson; L Mangogna
Journal:  Am J Pediatr Hematol Oncol       Date:  1986

9.  Use of intravenous methylprednisolone in acute idiopathic thrombocytopenic purpura.

Authors:  S Jayabose; P Patel; S Inamdar; R Brilliant; R Mamtani
Journal:  Am J Pediatr Hematol Oncol       Date:  1987

Review 10.  The pathogenesis of chronic immune thrombocytopenic purpura.

Authors:  Robert McMillan
Journal:  Semin Hematol       Date:  2007-10       Impact factor: 3.851

View more
  6 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2013

2.  Immune Thrombocytopenia and Obesity: Predictive Relationship.

Authors:  Ehab Hanafy; Mohammed Al Pakra
Journal:  Ochsner J       Date:  2017

Review 3.  Phytochemicals as potential therapeutics for thrombocytopenia.

Authors:  K Manasa; R Soumya; R Vani
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

4.  Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group.

Authors:  M Eva Mingot-Castellano; M Teresa Álvarez Román; Luis Fernando Fernández Fuertes; Tomás José González-López; José María Guinea de Castro; Isidro Jarque; M Fernanda López-Fernández; Maria Luisa Lozano; Blanca Sánchez González; David Valcárcel Ferreiras; José Ramón González Porras
Journal:  Adv Hematol       Date:  2019-08-22

5.  Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine.

Authors:  Srikrishna V Malayala; Gisha Mohan; Deepa Vasireddy; Paavani Atluri
Journal:  Cureus       Date:  2021-03-25

6.  Clinical feature and management of immune thrombocytopenic purpura in a tertiary hospital in Northwest Nigeria.

Authors:  Abdulaziz Hassan; Adeshola Adebayo; Abubakar Umar Musa; Aishatu Maude Suleiman; Ismaila Nda Ibrahim; Ibrahim Usman Kusfa; Mohammed Sirajo Aminu
Journal:  Niger Med J       Date:  2017 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.